Liminatus Pharma (LIMN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $3.21, -1.23% vs the prior close of $3.25.
- Volume 15.80K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LIMN dips 1.2% to $3.21, a 52-week low, 4 down days in a row. Closed at $3.21, -1.23% vs the prior close of $3.25. Day range $3.21–$3.36, opened at $3.30.
LIMN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — LIMN dips 1.2% to $3.21, a 52-week low, 4 down days in a row
- Closed at $3.21, -1.23% vs the prior close of $3.25. Day range $3.21–$3.36, opened at $3.30.
- Volume was 15.80K shares, 0.1x its 50-day average of 266.54K — lighter than usual.
- Price is -25.7% vs its 50-day average ($4.32) and -75.2% vs its 200-day average ($12.94).
- 52-week range $3.21–$141.50; today's close sits at 0% of that range, 97.7% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — LIMN slides 4.7% to $3.25, a 52-week low, 3 down days in a row
- Closed at $3.25, -4.69% vs the prior close of $3.41. Day range $3.25–$3.55, opened at $3.50.
- Volume was 20.10K shares, 0.1x its 50-day average of 268.10K — lighter than usual.
- Price is -25.5% vs its 50-day average ($4.36) and -75.2% vs its 200-day average ($13.09).
- 52-week range $3.25–$141.50; today's close sits at 0% of that range, 97.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — LIMN dips 1.2% to $3.41
- Closed at $3.41, -1.16% vs the prior close of $3.45. Day range $3.41–$3.62, opened at $3.62.
- Volume was 13.70K shares, 0.0x its 50-day average of 276.65K — lighter than usual.
- Price is -22.7% vs its 50-day average ($4.41) and -74.2% vs its 200-day average ($13.23).
- 52-week range $3.29–$141.50; today's close sits at 0% of that range, 97.6% below the 52-week high.
Oct 12, 2026 — LIMN slides 8.2% to $3.45
- Closed at $3.45, -8.24% vs the prior close of $3.76. Day range $3.40–$3.82, opened at $3.70.
- Volume was 28.80K shares, 0.1x its 50-day average of 277.93K — lighter than usual.
- Price is -22.6% vs its 50-day average ($4.46) and -74.2% vs its 200-day average ($13.39).
- 52-week range $3.29–$141.50; today's close sits at 0% of that range, 97.6% below the 52-week high.
Oct 9, 2026 — LIMN rises 1.9% to $3.76
- Closed at $3.76, +1.90% vs the prior close of $3.69. Day range $3.56–$3.81, opened at $3.56.
- Volume was 16.90K shares, 0.1x its 50-day average of 278.31K — lighter than usual.
- Price is -16.3% vs its 50-day average ($4.49) and -72.3% vs its 200-day average ($13.56).
- 52-week range $3.29–$141.50; today's close sits at 0% of that range, 97.3% below the 52-week high.
Oct 8, 2026 — LIMN slides 4.9% to $3.69
- Closed at $3.69, -4.90% vs the prior close of $3.88. Day range $3.53–$3.95, opened at $3.95.
- Volume was 38.60K shares, 0.1x its 50-day average of 278.27K — lighter than usual.
- Price is -18.4% vs its 50-day average ($4.52) and -73.1% vs its 200-day average ($13.73).
- 52-week range $3.29–$141.50; today's close sits at 0% of that range, 97.4% below the 52-week high.
Oct 7, 2026 — LIMN jumps 4.9% to $3.88
- Closed at $3.88, +4.86% vs the prior close of $3.70. Day range $3.65–$3.89, opened at $3.70.
- Volume was 22.90K shares, 0.1x its 50-day average of 278.44K — lighter than usual.
- Price is -14.8% vs its 50-day average ($4.55) and -72.1% vs its 200-day average ($13.91).
- 52-week range $3.29–$141.50; today's close sits at 0% of that range, 97.3% below the 52-week high.
Oct 6, 2026 — LIMN slides 7.3% to $3.70
- Closed at $3.70, -7.27% vs the prior close of $3.99. Day range $3.69–$3.95, opened at $3.95.
- Volume was 12.50K shares, 0.0x its 50-day average of 279.78K — lighter than usual.
- Price is -19.2% vs its 50-day average ($4.58) and -73.7% vs its 200-day average ($14.09).
- 52-week range $3.29–$141.50; today's close sits at 0% of that range, 97.4% below the 52-week high.
Oct 5, 2026 — LIMN rises 2.3% to $3.99, 3 up days in a row
- Closed at $3.99, +2.31% vs the prior close of $3.90. Day range $3.80–$4.08, opened at $3.80.
- Volume was 18.00K shares, 0.1x its 50-day average of 280.63K — lighter than usual.
- Price is -13.4% vs its 50-day average ($4.61) and -72.0% vs its 200-day average ($14.27).
- 52-week range $3.29–$141.50; today's close sits at 1% of that range, 97.2% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — LIMN jumps 4.0% to $3.90
- Closed at $3.90, +4.00% vs the prior close of $3.75. Day range $3.75–$3.95, opened at $3.75.
- Volume was 24.30K shares, 0.1x its 50-day average of 280.98K — lighter than usual.
- Price is -15.9% vs its 50-day average ($4.64) and -73.0% vs its 200-day average ($14.45).
- 52-week range $3.29–$141.50; today's close sits at 0% of that range, 97.2% below the 52-week high.
LIMN latest news & SEC filings
Every SEC filing by or about LIMN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.41M (prior year $113.29K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.03 (prior year $0.00)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
- Item 8.01 — Reported other events the company considers important.
Jul 22, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 14, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 13, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 6, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 3.02 — Sold unregistered shares.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Jun 30, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Things to know before you trade LIMN
- How much it moves: over the last 20 sessions the average daily move was 4.00% (largest 11.8%). That is a volatile stock.
- Liquidity: about 24.25K shares (≈$77.83K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.21 vs a range of $3.21–$141.50 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:50 on Aug 21, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 8-K Aug 18, 2026; 10-Q Aug 14, 2026.
- Share count: 67.16M shares outstanding (Aug 14, 2026), +158.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
LIMN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 3.30 | 3.36 | 3.21 | 3.21 | 15.80K |
| Oct 14, 2026 | 3.50 | 3.55 | 3.25 | 3.25 | 20.10K |
| Oct 13, 2026 | 3.62 | 3.62 | 3.41 | 3.41 | 13.70K |
| Oct 12, 2026 | 3.70 | 3.82 | 3.40 | 3.45 | 28.80K |
| Oct 9, 2026 | 3.56 | 3.81 | 3.56 | 3.76 | 16.90K |
| Oct 8, 2026 | 3.95 | 3.95 | 3.53 | 3.69 | 38.60K |
| Oct 7, 2026 | 3.70 | 3.89 | 3.65 | 3.88 | 22.90K |
| Oct 6, 2026 | 3.95 | 3.95 | 3.69 | 3.70 | 12.50K |
| Oct 5, 2026 | 3.80 | 4.08 | 3.80 | 3.99 | 18.00K |
| Oct 2, 2026 | 3.75 | 3.95 | 3.75 | 3.90 | 24.30K |
| Oct 1, 2026 | 3.74 | 3.86 | 3.65 | 3.75 | 28.20K |
| Sep 30, 2026 | 3.81 | 3.97 | 3.71 | 3.73 | 9.10K |
| Sep 29, 2026 | 4.23 | 4.31 | 3.83 | 3.91 | 38.40K |
| Sep 28, 2026 | 4.14 | 4.48 | 4.13 | 4.27 | 18.50K |
| Sep 25, 2026 | 4.26 | 4.34 | 4.09 | 4.20 | 17.70K |
| Sep 24, 2026 | 4.16 | 4.23 | 4.00 | 4.18 | 16.80K |
| Sep 23, 2026 | 4.05 | 4.14 | 3.90 | 4.03 | 17.20K |
| Sep 22, 2026 | 3.71 | 4.26 | 3.64 | 4.07 | 88.30K |
| Sep 21, 2026 | 3.68 | 3.72 | 3.56 | 3.64 | 16.00K |
| Sep 18, 2026 | 3.43 | 3.67 | 3.41 | 3.48 | 23.10K |
About Liminatus Pharma
Liminatus Pharma (LIMN) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in CERRITOS, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1971387.
LIMN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Chris Kim | Chief Executive Officer | Jul 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Chris Kim | Chief Executive Officer | Jul 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
LIMN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-10.21M | -0.43 | $-9.96M |
| Dec 31, 2024 | — | $-3.55M | -0.20 | $-1.45M |
Latest balance sheet: total assets $3.40M, total liabilities $3.10M, cash $— (as of Jun 30, 2026).
LIMN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on LIMN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.